Following in New York's footsteps, California's state health department has sent cease-and-desist orders to 13 consumer genomics companies, reports Forbes.com. In California, the law is that laboratory tests -- including genetic tests -- have to be ordered by a physician and must be validated for accuracy and medical utility. A spokeswoman said that California's investigation was prompted by consumer complaints. "The consumers were unhappy about the accuracy [of the tests] and thought they cost too much," she said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.